deltatrials
Completed PHASE4 INTERVENTIONAL 4-arm NCT05685732

An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD (KP415P01)

A Multicenter, Dose-Optimized, Randomized, Double Blind, Efficacy and Safety Study With Azstarys® in Children 4 to 12 Years of Age With Attention Deficit/Hyperactivity Disorder

Sponsor: Almac

Updated 10 times since 2023 Last updated: May 12, 2025 Started: Mar 22, 2023 Primary completion: May 2, 2024 Completion: May 2, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Attention Deficit/Hyperactivity Disorder and is currently completed. Almac leads this study, which shows 10 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshotNot Yet Recruiting~Mar 2023 – ~Jun 2023 · 3 months · monthly snapshotRecruiting~Jun 2023 – ~Feb 2024 · 8 months · monthly snapshotRecruiting~Feb 2024 – ~May 2024 · 3 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Aug 2024 · 31 days · monthly snapshotActive Not Recruiting~Aug 2024 – ~Sep 2024 · 31 days · monthly snapshotCompleted~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotCompleted~Jun 2025 – ~Dec 2025 · 6 months · monthly snapshotCompleted~Dec 2025 – present · 7 months · monthly snapshotCompleted

Change History

10 versions recorded
  1. Dec 2025 — Present [monthly]

    Completed PHASE4

  2. Jun 2025 — Dec 2025 [monthly]

    Completed PHASE4

  3. Sep 2024 — Jun 2025 [monthly]

    Completed PHASE4

  4. Aug 2024 — Sep 2024 [monthly]

    Completed PHASE4

    Status: Active Not RecruitingCompleted

  5. Jul 2024 — Aug 2024 [monthly]

    Active Not Recruiting PHASE4

Show 5 earlier versions
  1. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

    Status: RecruitingActive Not Recruiting

  2. Feb 2024 — May 2024 [monthly]

    Recruiting PHASE4

  3. Jun 2023 — Feb 2024 [monthly]

    Recruiting PHASE4

  4. Mar 2023 — Jun 2023 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  5. Feb 2023 — Mar 2023 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Almac
  • Corium, Inc.
  • Premier Research
  • Prometrika, LLC
Data source: Corium, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .